Current Assets
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value
MetLife AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value decreased by 5.4% to $112.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.8%, from $118.09B to $112.48B. Over 5 years (FY 2020 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value shows an upward trend with a 80.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2020
Last reportedQ1 2026May 7, 2026
Metric ID:
afs_trading_securities_unrealized_loss_12m_plus_fvHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.45B | $9.35B | $13.22B | $18.72B | $18.12B | $26.36B | $41.42B | $100.41B | $136.35B | $146.08B | $152.09B | $145.36B | $142.62B | $136.47B | $119.98B | $118.09B | $113.71B | $112.56B | $118.92B | $112.48B |
| QoQ Change | — | +10.6% | +41.4% | +41.6% | -3.2% | +45.5% | +57.1% | +142.4% | +35.8% | +7.1% | +4.1% | -4.4% | -1.9% | -4.3% | -12.1% | -1.6% | -3.7% | -1.0% | +5.7% | -5.4% |
| YoY Change | — | — | — | — | +114.3% | +182.0% | +213.2% | +436.3% | +652.5% | +454.1% | +267.2% | +44.8% | +4.6% | -6.6% | -21.1% | -18.8% | -20.3% | -17.5% | -0.9% | -4.8% |
Range$8.45B – $152.09B
CAGR+72.4%
Avg YoY Growth+142.4%
Median YoY Growth+24.7%
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value at Other Companies
Frequently Asked Questions
- What is MetLife's afs and trading securities - unrealized loss position (>=12 months) fair value?
- MetLife (MET) reported afs and trading securities - unrealized loss position (>=12 months) fair value of $112.48B in Q1 2026.
- How has MetLife's afs and trading securities - unrealized loss position (>=12 months) fair value changed year-over-year?
- MetLife's afs and trading securities - unrealized loss position (>=12 months) fair value decreased by 4.8% year-over-year, from $118.09B to $112.48B.
- What is the long-term trend for MetLife's afs and trading securities - unrealized loss position (>=12 months) fair value?
- Over 5 years (2020 to 2025), MetLife's afs and trading securities - unrealized loss position (>=12 months) fair value has grown at a 80.3% compound annual growth rate (CAGR), from $6.24B to $118.92B.